Agomab Therapeutics
  • Home
  • About Us
    • About Us
    • Executive Committee
    • Board of Directors
    • Investors & Partners
  • Our Science
    • Our Science
    • Publications
  • Our Pipeline
    • Our Pipeline
    • AGMB-129
    • AGMB-447
    • AGMB-101-102
    • Expanded Access
  • News & Events
    • Press Releases
    • Agomab in the news
    • Meet Us
  • Connect with Us
    • Contact us
    • Locations
  • Work with us
Agomab Therapeutics
  • Home
  • About Us
    • About Us
    • Executive Committee
    • Board of Directors
    • Investors & Partners
  • Our Science
    • Our Science
    • Publications
  • Our Pipeline
    • Our Pipeline
    • AGMB-129
    • AGMB-447
    • AGMB-101-102
    • Expanded Access
  • News & Events
    • Press Releases
    • Agomab in the news
    • Meet Us
  • Connect with Us
    • Contact us
    • Locations
  • Work with us

Posts by author: Ante

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Recent Posts

  • Late-Breaking Interim STENOVA Data for AGMB-129 in Fibrostenosing Crohn’s to be Presented at Digestive Disease Week® 2025
  • Agomab Announces Positive Topline Phase 2a Interim Results for AGMB-129 in Fibrostenosing Crohn’s Disease
  • Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors
  • Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis- focused Pipeline
  • Agomab Bolsters Executive Team with Appointment of Pierre Kemula as Chief Financial Officer

Recent Comments

    Archives

    • April 2025
    • March 2025
    • November 2024
    • October 2024
    • July 2024
    • June 2024
    • December 2023
    • November 2023
    • October 2023
    • February 2023
    • September 2022
    • July 2022
    • January 2022
    • December 2021
    • October 2021
    • July 2021
    • June 2021
    • March 2021
    • October 2019
    • April 2019

    Categories

    • –
    • 2019
    • 2021
    • 2022
    • 2023
    • 2024
    • 2025
    • All

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Legal
    Copyright © 2025 Agomab Therapeutics